AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2025
May 14, 2025
30339_dirs_2025-05-14_e5039cb5-74e5-4e98-92ef-b4cc194f0701.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2025-05-05
Reporting Person: Campbell Shane Alden (SVP, Proprietary Segment)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Rst. Stock Unit | $0 | Common Stock (1891) | Direct | ||
| Rst. Stock Unit | $0 | Common Stock (1182) | Direct | ||
| Stock Options (Right to Buy) | $219.46 | 2035-05-12 | Stock Options (Right to Buy) (2852) | Direct |
Footnotes
F1: This award vests in four equal annual installments beginning on May 12, 2026.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27